3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
5
Rhabdoid Tumor
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Osteosarcoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Pancreatic Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Non functioning pancreatic endocrine tumor
1
Neoplasm Metastasis
1
Lymphoma, B-Cell
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Carcinoma, Non-Small-Cell Lung
1
Adenoma, Islet Cell
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Phantoms, Imaging
×
Clear all
No trials found.